Atlas Trials

Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study

Clinical trial NCT04398368 · TERMINATED

Trial details

NCT number
NCT04398368
Sponsor
Mayo Clinic
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Stage 0a Renal Pelvis and Ureter Cancer AJCC v8Stage 0a Renal Pelvis Cancer AJCC v8Stage 0a Ureter Cancer AJCC v8Stage 0is Renal Pelvis and Ureter Cancer AJCC v8Stage 0is Renal Pelvis Cancer AJCC v8Stage 0is Ureter Cancer AJCC v8Stage I Renal Pelvis and Ureter Cancer AJCC v8Stage I Renal Pelvis Cancer AJCC v8Stage I Ureter Cancer AJCC v8Stage II Renal Pelvis and Ureter Cancer AJCC v8Stage II Renal Pelvis Cancer AJCC v8Stage II Ureter Cancer AJCC v8
Start date
2020-06-05
Primary completion
2023-02-02
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.